Alnylam Gets VIP Status as the FDA Slaps Breakthrough Tag on Patisiran Post author:Sam Post published:November 19, 2017 Post category:BioPharma The company is weeks away from completing its rolling NDA for Patisiran. Source: BioSpace You Might Also Like GTX Corp Provides Corporate Update And Reports Second Quarter 2017 Financial Results August 13, 2017 Bristol-Myers Squibb Inks Two Separate Pacts With Biogen and Roche For a Total of Up to $1.1B April 12, 2017 What and His Potential Nominees Should Understand About the FDA January 18, 2017
Bristol-Myers Squibb Inks Two Separate Pacts With Biogen and Roche For a Total of Up to $1.1B April 12, 2017
